In contrast to alpha-tocopherol, our finding demonstrated the effectiveness of ascorbic acid in reducing fasting insulin and HOMA-IR% in type 2 diabetes patients (Table 1). The gene discussed is INS; the disease is type 2 diabetes mellitus.